Clinical trial
Family Presence in the Intensive Care Unit: Impact of an Expanded Visiting Policy on Healthcare Professionals' Attitudes and Experiences During the Transition to a New Unit With Individual Patient Rooms
NCT07887009 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Family Presence in the Intensive Care Unit: Impact of an Expanded Visiting Policy on Healthcare Professionals' Attitudes and Experiences During the Transition to a New Unit With Individual Patient Rooms
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- September 29, 2026
- Completion date
- December 30, 2027
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adaptation to extended family presence in the icu, association between stress sensitivity and attitudes toward family presence, icu staff attitudes toward family presence, icu staff experience of family presence
Arms
As registered; 1 arm.
-
questionnaire on attitudes and validation of family participation on ICU
questionnaire
Primary endpoints
Registered primary outcome measures; 2 primary.
-
Changes from baseline in healthcare providers'attitudes and perceptions regarding family presence in the adult ICU (Intensive Care Unit)
The change in healthcare providers' attitudes and perceptions is measured using the BAVIQ score prior to the introduction of the more flexible visitation policy (baseline) and six months after implementation (Follow-up) . The primary out is the change in the BAVIQ score between the baseline measurements and Follow-up.
No predifined threshold is used; scores are analysed as continuous measures.
Time points:
T0 = baseline time point, before implementation of the extended visiting policy.
T1 = implementation time point, during the early implementation period of the extended visiting policy.
T2 = follow-up time point, approximately 6 months after implementation of the extended visiting policy.
-
association between individual vulnerability to stress and overload and attitudes and perceptions regarding family presence.
The susceptibility to individual vulnerability to stress and overload is measured using the IPIP-NEO facet scales for Anxiety and Vulnerability at baseline. The outcome measures are the IPIP-NEO Anxiety and Vulnerability facet scores, their association with the BAVIQ score at baseline, and their association with the change in the BAVIQ score between baseline and follow up.
Time points:
T0 = baseline time point, before implementation of the extended visiting policy.
T1 = implementation time point, during the early implementation period of the extended visiting policy.
T2 = follow-up time point, approximately 6 months after implementation of the extended visiting policy.
Papers
PubMed papers this trial cites; 6 papers, results papers first, then newest first.
+1 more paper
Lead sponsor's other trials
Universitair Ziekenhuis Brussel, most recent start first.
+387 more trials See the organization page